Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,372 articles

Articles by Daniel Marsh

Opendoor Prepares for Russell 3000 Inclusion Amid Housing Market Challenges
Markets

Opendoor Prepares for Russell 3000 Inclusion Amid Housing Market Challenges

Opendoor shares rose 0.8% to $4.34 as investors position for Russell 3000 inclusion. Q1 revenue fell to $720M with a $173M net loss, and the company warns of mortgage rate and housing market risks.

OPEN ZG
T1 Energy Shares Slide 7.4% on Dilution Fears from KORE Deal Filing
Markets

T1 Energy Shares Slide 7.4% on Dilution Fears from KORE Deal Filing

T1 Energy shares plunged 7.4% to $8.46 on dilution fears after a filing detailed stock-based payments for the KORE Power acquisition, with share count tied to a 10-day VWAP.

Navitas Shares Drop 6.6% on $500M Stock Sale Plan and Board Departure
Markets

Navitas Shares Drop 6.6% on $500M Stock Sale Plan and Board Departure

Navitas shares fell 6.6% to $22.85 after the company unveiled a $500M stock sale program and a board resignation, with broader chip sector weakness adding pressure.

NVTS
Epsium Enterprise Rockets 72% in Wild Nasdaq Session Then Plunges
Markets

Epsium Enterprise Rockets 72% in Wild Nasdaq Session Then Plunges

Epsium Enterprise shares skyrocketed 72% on massive volume, then fell 18.5% after hours. The Macau beverage wholesaler's rally comes despite declining revenue and a net loss.

EPSM
Hims & Hers Health Surges on Weight-Loss Drug Strategy Optimism
Analysis

Hims & Hers Health Surges on Weight-Loss Drug Strategy Optimism

Hims & Hers Health (HIMS) shares rallied 6.6% to $28.98 on heavy volume, bucking a tech selloff, as investors refocus on the company's weight-loss drug scaling potential after a challenging quarter.

HIMS NVO LLY
RBC Shares Surge to 52-Week High Amid Mixed Toronto Market
Markets

RBC Shares Surge to 52-Week High Amid Mixed Toronto Market

RBC shares hit a 52-week high of C$277.09, closing up 1.24% at C$276.01, after Q2 net income of C$5.5 billion beat estimates, as the TSX slipped 0.2%.

RY CM BNS TD
BigBear.ai Shares Slide as Panama AI Contract and Dilution Fears Weigh
Markets

BigBear.ai Shares Slide as Panama AI Contract and Dilution Fears Weigh

BigBear.ai shares dropped 33 cents to $3.98 as the market weighed a Panama cargo security deployment, annual meeting outcomes, and persistent losses. While backlog rose 14% and cash stands at $431.5 million, revenue conversion concerns and dilution risks persist.

BBAI PLTR AI
PERA Bonuses Stir Debate as Pensions Lag Inflation
Analysis

PERA Bonuses Stir Debate as Pensions Lag Inflation

Colorado PERA awarded $11.7M in bonuses to investment staff after a $9.8B loss in 2022, while retirees' pensions have lost 21% buying power since 2010.

XLV
Tech Selloff Deepens Ahead of CPI, IPOs; Nasdaq Slides 1.2%
Markets

Tech Selloff Deepens Ahead of CPI, IPOs; Nasdaq Slides 1.2%

U.S. stocks closed mixed Tuesday as a tech bounce faded, sending the Nasdaq down 1.21%. The S&P 500 fell 0.53%, while the Dow edged up. AI and chip stocks were volatile ahead of Wednesday's CPI report and a busy IPO calendar.

AAPL AMD MRVL MU ORCL
Nasdaq Drops 1.2% as Tech Selloff Widens; Dow Flat
Markets

Nasdaq Drops 1.2% as Tech Selloff Widens; Dow Flat

Tech stocks plunged, dragging the Nasdaq down 1.21% as investors sold AI and chip shares ahead of key inflation data and after President Trump called for a response to Iran.

MU MRVL AMD HD SHW NKE CRM AAPL CSCO
Nvidia Slips Despite Apple AI Win as Tech Selloff Intensifies
Markets

Nvidia Slips Despite Apple AI Win as Tech Selloff Intensifies

Nvidia shares dropped 1.8% despite Apple's AI endorsement, as tech selloff and macro concerns weighed. Investors question if AI demand is already priced in.

NVDA AAPL AMD AVGO MRVL
POET Technologies Tumbles 13% Amid Legal Woes, AI Chip Selloff
Markets

POET Technologies Tumbles 13% Amid Legal Woes, AI Chip Selloff

POET Technologies dropped 13% as legal risks and a canceled Marvell order weighed on shares, despite a $50 million Lumilens deal and $400 million funding. AI chip stocks also slumped.

POET MRVL AAOI QQQ SOXX